New Methods in Cancer Screening and Detection Methods
Sunday, March 8, 2026 8:30 AM to 11:00 AM · 2 hr. 30 min. (America/Chicago)
Room 225C
Oral
Bioanalytical & Life Science
Information
Developments in Lab-on-a-Chip, Microfluidics, and Imaging techniques towards cancer detection and diagnosis.
Day of Week
Sunday
Session or Presentation
Session
Session Number
OR-33-00
Application
Bioanalytical
Methodology
Microfluidics/Lab-on-a-Chip
Primary Focus
Application
Morning or Afternoon
Morning
Register
No Registered for Pittcon? Register Now!
Presentations
Decellularized Tissue Scaffold: a Novel Platform for Expanding Circulating Tumor Cells of Pancreatic Cancer
Sunday, March 8, 2026 8:30 AM to 8:50 AM
Room 225C
Yu Zhang · University of Michigan
Development of a Magneto-Electrochemical Point of Care Platform for Early Detection and Monitoring of Breast Cancer using Laser-Induced Graphene Electrodes
Sunday, March 8, 2026 8:50 AM to 9:10 AM
Room 225C
Nicole Villarini · Colorado State University
Nanophotonic Liquid Biopsy of Circulating Tumor Exosomes for Point-of-care Cancer Detection
Sunday, March 8, 2026 9:10 AM to 9:30 AM
Room 225C
Wei-Chuan Shih · University of Houston
Functional Nucleic Acid-Based Magnetic Nanomachine-Driven Lateral Flow Strip for Highly Sensitive Detection of Colorectal Cancer Biomarker miR-141
Sunday, March 8, 2026 9:40 AM to 10:00 AM
Room 225C
Jia-Ying Weng · Chun Yuan Christian University, Department of Chemistry
Profile of Extracellular Vesicle Proteins by a Plasmonic Fluorophores-enabled Chip Assay for Ovarian Cancer Diagnosis
Sunday, March 8, 2026 10:00 AM to 10:20 AM
Room 225C
Yuxin Deng · University of Florida
A Microfluidic Chip and Molecularly Imprinted Biosensing Platform for Early Detection of Breast Cancer-Derived Extracellular Vesicles
Sunday, March 8, 2026 10:20 AM to 10:40 AM
Room 225C
Yeseren Saylan Inci · Hacettepe University
Optical Imaging Using SESORRS Reveals Deep-Seated Tumors in Preclinical Cancer Models
Sunday, March 8, 2026 10:40 AM to 11:00 AM
Room 225C
Fay Nicolson · Dana-Farber Cancer Institute